TRENTINI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 11.537
AS - Asia 6.736
EU - Europa 3.990
SA - Sud America 983
Continente sconosciuto - Info sul continente non disponibili 418
AF - Africa 167
OC - Oceania 23
AN - Antartide 1
Totale 23.855
Nazione #
US - Stati Uniti d'America 11.222
SG - Singapore 2.585
CN - Cina 1.507
IT - Italia 1.171
BR - Brasile 767
VN - Vietnam 746
PL - Polonia 512
HK - Hong Kong 505
DE - Germania 504
GB - Regno Unito 340
BD - Bangladesh 323
FI - Finlandia 281
UA - Ucraina 273
TR - Turchia 266
FR - Francia 215
JP - Giappone 179
IN - India 160
CA - Canada 157
RU - Federazione Russa 140
ID - Indonesia 131
SE - Svezia 123
MX - Messico 100
NL - Olanda 79
AR - Argentina 72
ZA - Sudafrica 60
IQ - Iraq 59
IE - Irlanda 49
BE - Belgio 46
AT - Austria 45
CO - Colombia 45
ES - Italia 44
CZ - Repubblica Ceca 36
EC - Ecuador 34
PK - Pakistan 29
MA - Marocco 28
LT - Lituania 25
PH - Filippine 24
AE - Emirati Arabi Uniti 22
IR - Iran 22
UZ - Uzbekistan 22
MY - Malesia 20
SA - Arabia Saudita 20
VE - Venezuela 20
KR - Corea 18
AU - Australia 17
TW - Taiwan 16
CL - Cile 15
JM - Giamaica 15
RO - Romania 15
KE - Kenya 13
TN - Tunisia 13
EG - Egitto 12
BG - Bulgaria 11
OM - Oman 11
PY - Paraguay 11
NP - Nepal 10
PT - Portogallo 10
CH - Svizzera 9
AL - Albania 8
DZ - Algeria 8
AZ - Azerbaigian 7
ET - Etiopia 7
HN - Honduras 7
JO - Giordania 7
KZ - Kazakistan 7
PE - Perù 7
SD - Sudan 7
SI - Slovenia 6
UY - Uruguay 6
BO - Bolivia 5
BY - Bielorussia 5
GT - Guatemala 5
HU - Ungheria 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
AO - Angola 4
BB - Barbados 4
CR - Costa Rica 4
EU - Europa 4
GE - Georgia 4
IL - Israele 4
KW - Kuwait 4
LV - Lettonia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RS - Serbia 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
DK - Danimarca 3
EE - Estonia 3
GD - Grenada 3
GR - Grecia 3
HR - Croazia 3
LB - Libano 3
NO - Norvegia 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
Totale 23.400
Città #
Singapore 1.633
Ashburn 1.472
San Jose 1.081
Fairfield 776
Woodbridge 701
Santa Clara 545
Beijing 513
Ann Arbor 492
Hong Kong 492
Warsaw 478
Chandler 452
Houston 440
Ferrara 347
Jacksonville 320
Dallas 311
Seattle 292
Wilmington 261
Cambridge 252
Council Bluffs 228
Los Angeles 224
Ho Chi Minh City 218
New York 210
Tokyo 171
Izmir 157
Hanoi 153
Helsinki 150
Munich 144
Nanjing 121
Lauterbourg 118
Princeton 115
Milan 106
Menlo Park 98
Jakarta 97
Bologna 95
Shanghai 91
Boardman 83
São Paulo 73
London 67
Mexico City 62
Orem 62
Buffalo 58
Toronto 56
Dearborn 55
San Diego 54
Turku 53
Montreal 49
Addison 48
Brooklyn 47
Chicago 46
Rome 46
Chennai 44
Brussels 43
Nanchang 42
Shenyang 40
Haiphong 39
Johannesburg 39
The Dalles 39
Bremen 37
Da Nang 36
Hefei 35
Nuremberg 35
San Francisco 35
Frankfurt am Main 34
Phoenix 34
Stockholm 34
Tianjin 34
Boston 32
Denver 32
Poplar 31
Atlanta 30
Amsterdam 29
Dong Ket 27
Moscow 27
Vienna 27
Falkenstein 26
Falls Church 26
Manchester 26
Changsha 25
Ankara 24
Brno 24
St Louis 24
Baghdad 22
Columbus 22
Belo Horizonte 21
Jiaxing 21
Mumbai 21
Guangzhou 20
Brasília 19
Paris 19
Tashkent 19
Hebei 18
Redwood City 18
Rio de Janeiro 18
Washington 18
Biên Hòa 16
Curitiba 16
Hải Dương 16
Lappeenranta 16
Norwalk 16
Charlotte 15
Totale 15.574
Nome #
Gelatinases, Neurofilaments and N-Acetyl aspartic Acid as Biomarkers in Different Pathologies 342
Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease 338
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 326
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia 305
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 303
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 275
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 272
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 257
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 255
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 252
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 252
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 252
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 251
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 248
Influence of Vaginal Lactoferrin Administration on Amniotic Fluid Cytokines and its Role Against Inflammatory Complications of Pregnancy 244
Study of the potential influence of obesity on the activities of serum Paraoxonase-1 and lipoprotein-associated phospholipase A2 244
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 244
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 244
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 239
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 236
Extrapulmonary tuberculosis among immigrants in a low-TB burden and high immigrant receiving city of northern Italy 231
Evaluation of a possible role of oxidative stress in climacteric symptoms. 230
Epidemiologia ed Outcome delle Infezioni della Cute e dei Tessuti Molli Osservate a Ferrara nel Quinquennio 2011-2016 230
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women 229
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 228
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 228
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 223
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 221
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 218
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 214
Leptin/adiponectin ratio predicts post-stroke neurological outcome 213
Implication of oxidative stress in dementia: data from cross-sectional and longitudinal study 212
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 209
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 207
Serum from patients affected by Alzheimer disease shows a paraoxonase-dependent pro-apoptotic effect on endothelial cells 207
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 203
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 202
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 196
Proteomic analysis of 4-hydroxynonenal and nitrotyrosine modified proteins in RTT fibroblasts 195
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 193
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 193
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 192
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 191
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 191
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 189
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 187
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 187
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 186
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 186
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 185
Acute Prosthetic Joint Infections with Poor Outcome Caused by Staphylococcus Aureus Strains Producing the Panton-Valentine Leukocidin 184
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 184
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 182
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 182
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 182
Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors 181
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 180
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 177
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 176
A Nutraceutical Compound Containing a Low Dose of Monacolin K, Polymethoxyflavones, Phenolic Acids, Flavonoids, and Hydroxytyrosol Improves HDL Functionality 174
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 169
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 168
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 168
null 163
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 162
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 162
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 161
Fermentation of Vaccinium floribundum Berries with Lactiplantibacillus plantarum Reduces Oxidative Stress in Endothelial Cells and Modulates Macrophages Function 159
Brain and serum cholesterol dyshomeostasis during the perimenopausal transition: A possible risk factor for Alzheimer’s disease 158
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 156
Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment 156
PON1 and PON3 in Alzheimer's Disease: Similar Functions but Different Roles 155
EVALUATION OF THE SWITCH TO A DUAL ART REGIMEN WITH LAMIVUDINE PLUS DOLUTEGRAVIR OR PROTEASE INHIBITORS IN HIV-INFECTED VIROLOGICALLY SUPPRESSED PATIENTS. A REAL LIFE EXPERIENCE 153
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease 153
Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia 153
Age, Sex, Hypertension and HDL-C Alter Serum BACE1 Activity in Cognitively Normal Subjects: Implications for Alzheimer's Disease 152
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 151
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 151
High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia 151
Brain and serum cholesterol metabolism during perimenopausal transition: a risk factor for Alzheimer’s disease? 149
Paraoxonase-1 and dementia-related diseases 148
Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis 147
Purification of transglutaminase enzyme from L. infantum promastigotes 142
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 142
Diaphragmatic dysfunction in critically patients undergoing mechanical ventilation 140
Clinical and Laboratory Findings in Tick-Borne Encephalitis Virus Infection 140
Inflammation in Neurological Disorders: The Thin Boundary between Brain and Periphery 139
Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease 138
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 138
HDL-Cholesterol Subfraction Dimensional Distribution Is Associated with Cardiovascular Disease Risk and Is Predicted by Visceral Adiposity and Dietary Lipid Intake in Women 137
Paraoxonase 1 activity in patients with Alzheimer disease: Systematic review and meta-analysis 136
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines 136
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 135
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: Insights from EVA study 133
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 133
Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia 132
Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis 131
MMP-9 isoforms in serum of Multiple Sclerosis patients 129
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 129
null 128
Totale 19.240
Categoria #
all - tutte 107.012
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 354
Totale 107.366


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.247 100 145 155 42 41 75 61 71 37 113 58 349
2022/20231.137 119 104 35 135 174 146 72 111 125 9 65 42
2023/2024864 67 84 37 24 94 98 42 78 44 33 43 220
2024/20253.595 106 98 292 148 442 330 146 211 573 416 466 367
2025/202610.650 909 427 779 1.105 1.381 740 1.543 622 922 1.136 673 413
2026/2027276 276 0 0 0 0 0 0 0 0 0 0 0
Totale 23.855